John Bamforth, director, Eshelman Institute for Innovation, University of North Carolina, Chapel Hill, on what it takes to bring the world's top pharmaceutical researchers and industry leaders in an open-science partnership to ensure we're ready for the next pandemic, the Rapidly Emerging Antiviral Drug Discovery Initiative (READDI).

"No one would have wished, of course, for COVID-19 to have become what it is. But in another sense, it really has galvanized people to think in a more collaborative way in order to get these global problems solved."

John Bamforth on open innovation and READDI (Rapidly Emerging Antiviral Drug Discovery Initiative)

Charles Johnson Bay, Senior Vice-President at Booz Allen Hamilton, discusses the digital battlespace and the need for industry & academic partnership for emerging technologies. The fundamental challenge that defense leaders face today is not picking winners, but accurately seeing global technology trends and being able to translate and adapt --because it's not who has the edge this year, or even this month, but this minute that matters.

John Bamforth on open innovation and READDI (Rapidly Emerging Antiviral Drug Discovery Initiative)

UIDP Conversations

Related tracks